Structural insights into non-covalent ubiquitin activation of the cIAP1-UbcH5B∼ubiquitin complex.

E3 ubiquitin ligase RING E3 UbcH5B activation allosteric regulation apoptosis cIAP1 non-covalent protein degradation structural biology ubiquitin ubiquitin ligase ubiquitin-conjugating enzyme (E2 enzyme) ubiquitylation (ubiquitination)

Journal

The Journal of biological chemistry
ISSN: 1083-351X
Titre abrégé: J Biol Chem
Pays: United States
ID NLM: 2985121R

Informations de publication

Date de publication:
25 01 2019
Historique:
received: 28 09 2018
revised: 30 11 2018
pubmed: 14 12 2018
medline: 30 4 2019
entrez: 8 12 2018
Statut: ppublish

Résumé

Ubiquitin (Ub)-conjugating enzymes and Ub ligases control protein degradation and regulate many cellular processes in eukaryotes. Cellular inhibitor of apoptosis protein-1 (cIAP1) plays a central role in apoptosis and tumor necrosis factor signaling. It harbors a C-terminal RING domain that homodimerizes to recruit E2∼Ub (where ∼ denotes a thioester bond) complex to catalyze Ub transfer. Noncovalent Ub binding to the backside of the E2 Ub-conjugating enzyme UbcH5 has previously been shown to enhance RING domain activity, but the molecular basis for this enhancement is unclear. To investigate how dimeric cIAP1 RING activates E2∼Ub for Ub transfer and what role noncovalently bound Ub has in Ub transfer, here we determined the crystal structure of the cIAP1 RING dimer bound to both UbcH5B covalently linked to Ub (UbcH5B-Ub) and a noncovalent Ub to 1.7 Å resolution. The structure along with biochemical analyses revealed that the cIAP1 RING domain interacts with UbcH5B-Ub and thereby promotes the formation of a closed UbcH5B-Ub conformation that primes the thioester bond for Ub transfer. We observed that the noncovalent Ub binds to the backside of UbcH5B and abuts UbcH5B's α1β1-loop, which, in turn, stabilizes the closed UbcH5B-Ub conformation. Our results disclose the mechanism by which cIAP1 RING dimer activates UbcH5B∼Ub and indicate that noncovalent Ub binding further stabilizes the cIAP1-UbcH5B∼Ub complex in the active conformation to stimulate Ub transfer.

Identifiants

pubmed: 30523153
pii: S0021-9258(20)38861-X
doi: 10.1074/jbc.RA118.006045
pmc: PMC6349121
pii:
doi:

Substances chimiques

Inhibitor of Apoptosis Proteins 0
Ubiquitin 0
UBE2D2 protein, human EC 2.3.2.23
Ubiquitin-Conjugating Enzymes EC 2.3.2.23

Banques de données

PDB
['3EB6', '4V3L', '4V3K', '3ZNI']

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1240-1249

Subventions

Organisme : Cancer Research UK
ID : A23278
Pays : United Kingdom

Informations de copyright

© 2019 Patel et al.

Références

Nat Struct Mol Biol. 2009 Jun;16(6):658-66
pubmed: 19465916
Mol Cell. 2006 Mar 17;21(6):873-80
pubmed: 16543155
J Biol Chem. 2003 Mar 14;278(11):9448-57
pubmed: 12524449
J Mol Biol. 2011 May 6;408(3):420-31
pubmed: 21396940
Proc Natl Acad Sci U S A. 2005 Nov 8;102(45):16182-7
pubmed: 16263936
Acta Crystallogr D Biol Crystallogr. 2010 Feb;66(Pt 2):125-32
pubmed: 20124692
Mol Cell. 2015 Apr 16;58(2):297-310
pubmed: 25801170
Nat Cell Biol. 2009 Feb;11(2):123-32
pubmed: 19136968
Biochem J. 2013 Mar 15;450(3):629-38
pubmed: 23259674
Nature. 2011 Mar 31;471(7340):591-6
pubmed: 21455173
Trends Cell Biol. 2016 Jun;26(6):445-461
pubmed: 26877205
PLoS One. 2011;6(9):e22356
pubmed: 21931591
Nat Struct Mol Biol. 2012 Sep;19(9):876-83
pubmed: 22902369
Science. 2011 Oct 21;334(6054):376-80
pubmed: 22021857
Nature. 2011 Mar 31;471(7340):633-6
pubmed: 21455180
Nat Commun. 2017 Nov 27;8(1):1788
pubmed: 29176576
Mol Cell. 2009 Dec 11;36(5):831-44
pubmed: 20005846
J Biol Chem. 2013 Jun 28;288(26):18939-46
pubmed: 23671280
Nat Struct Mol Biol. 2013 Aug;20(8):982-986
pubmed: 23851457
EMBO J. 2016 Jun 1;35(11):1204-18
pubmed: 27154206
Nat Rev Mol Cell Biol. 2016 Oct;17(10):626-42
pubmed: 27485899
Structure. 2010 Jan 13;18(1):138-47
pubmed: 20152160
Nat Methods. 2011 Jul 10;8(8):691-6
pubmed: 21743460
J Biol Chem. 2008 Nov 14;283(46):31633-40
pubmed: 18784070
Annu Rev Biophys Biomol Struct. 2007;36:131-50
pubmed: 17477837
Cancer Lett. 2013 May 28;332(2):206-14
pubmed: 20685035
Mol Cell. 2011 Apr 8;42(1):75-83
pubmed: 21474069
J Biol Chem. 2003 Mar 21;278(12):10055-60
pubmed: 12525502
J Biol Chem. 2015 Dec 18;290(51):30225-39
pubmed: 26475854
Cell. 2011 Mar 4;144(5):769-81
pubmed: 21376237
Nat Struct Mol Biol. 2016 Jan;23(1):45-52
pubmed: 26656854
Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32
pubmed: 15572765
J Biol Chem. 2008 Sep 5;283(36):24295-9
pubmed: 18621737
Proteins. 2017 Oct;85(10):1957-1961
pubmed: 28681414
Cell Rep. 2016 Aug 2;16(5):1315-1325
pubmed: 27425606
Acta Crystallogr D Biol Crystallogr. 2002 Nov;58(Pt 11):1948-54
pubmed: 12393927
Mol Cell. 2008 Jun 20;30(6):689-700
pubmed: 18570872
Mol Cell. 2012 Sep 28;47(6):933-42
pubmed: 22885007
Nat Struct Mol Biol. 2015 Aug;22(8):597-602
pubmed: 26148049
EMBO J. 2010 Dec 15;29(24):4198-209
pubmed: 21113135
Nature. 2012 Sep 6;489(7414):115-20
pubmed: 22842904
Nature. 2011 Mar 31;471(7340):637-41
pubmed: 21455181
J Biol Chem. 2006 Feb 10;281(6):3254-60
pubmed: 16339151
Biochim Biophys Acta. 2004 Nov 29;1695(1-3):55-72
pubmed: 15571809
Nat Struct Mol Biol. 2017 Jul;24(7):578-587
pubmed: 28553961
J Appl Crystallogr. 2007 Aug 1;40(Pt 4):658-674
pubmed: 19461840
J Biol Chem. 2009 May 8;284(19):12772-82
pubmed: 19258326
Mol Cell. 2011 Jun 10;42(5):569-83
pubmed: 21549626
Mol Biol Cell. 2008 Jul;19(7):2729-40
pubmed: 18434593
Annu Rev Biochem. 1998;67:425-79
pubmed: 9759494
J Biol Chem. 2011 May 13;286(19):17015-28
pubmed: 21393245

Auteurs

Amrita Patel (A)

Cancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, Scotland, United Kingdom; Institute of Cancer Sciences, University of Glasgow, Glasgow G61 1BD, Scotland, United Kingdom.

Gary J Sibbet (GJ)

Cancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, Scotland, United Kingdom; Institute of Cancer Sciences, University of Glasgow, Glasgow G61 1BD, Scotland, United Kingdom.

Danny T Huang (DT)

Cancer Research UK Beatson Institute, Garscube Estate, Switchback Road, Glasgow G61 1BD, Scotland, United Kingdom; Institute of Cancer Sciences, University of Glasgow, Glasgow G61 1BD, Scotland, United Kingdom. Electronic address: d.huang@beatson.gla.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH